Latest ARCH VENTURE CORP Stock Portfolio
About ARCH VENTURE CORP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ARCH Venture Management, LLC reported an equity portfolio of $492.4 Millions as of 30 Sep, 2025.
The top stock holdings of ARCH Venture Management, LLC are , BEAM, . The fund has invested 22.5% of it's portfolio in RAPPORT THERAPEUTICS INC. and 22.4% of portfolio in BEAM THERAPEUTICS INC.
The fund managers got completely rid off VERVE THERAPEUTICS INC. (VERV) and UNITY BIOTECHNOLOGY INC. (UBX) stocks. The fund showed a lot of confidence in some stocks as they added substantially to LYELL IMMUNOPHARMA INC. (LYEL).
The top stock holdings of ARCH Venture Management, LLC are , BEAM, . The fund has invested 22.5% of it's portfolio in RAPPORT THERAPEUTICS INC. and 22.4% of portfolio in BEAM THERAPEUTICS INC.
The fund managers got completely rid off VERVE THERAPEUTICS INC. (VERV) and UNITY BIOTECHNOLOGY INC. (UBX) stocks. The fund showed a lot of confidence in some stocks as they added substantially to LYELL IMMUNOPHARMA INC. (LYEL).
ARCH VENTURE CORP Annual Return Estimates Vs S&P 500
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| lyell immunopharma inc. | 51.54 |
Additions to existing portfolio by ARCH VENTURE CORP
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| verve therapeutics inc. | -22,558,900 |
| unity biotechnology inc. | -385,950 |
ARCH VENTURE CORP got rid off the above stocks
Sector Distribution
| Sector | % |
|---|---|
| Healthcare | 55.7 |
| Others | 44.3 |
Market Cap. Distribution
| Category | % |
|---|---|
| UNALLOCATED | 44.3 |
| SMALL-CAP | 29 |
| MID-CAP | 22.4 |
| MICRO-CAP | 4.3 |
Stocks belong to which Index?
| Index | % |
|---|---|
| RUSSELL 2000 | 51.4 |
| Others | 48.6 |
ARCH VENTURE CORP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ARCH VENTURE CORP
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| BEAM | beam therapeutics inc. | 22.38 | 4,540,130 | 110,189,000 | unchanged | 0.00 | ||
| ERAS | erasca inc. | 4.89 | 11,055,600 | 24,101,100 | unchanged | 0.00 | ||
| GOSS | gossamer bio inc. | 4.30 | 8,055,920 | 21,187,100 | unchanged | 0.00 | ||
| LYEL | lyell immunopharma inc. | 9.10 | 2,759,070 | 44,807,300 | added | 51.54 | ||
| PBAX | cero therapeutics holdings inc. | 0.02 | 22,389 | 113,960 | unchanged | 0.00 | ||
| UBX | unity biotechnology inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| VERV | verve therapeutics inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| VIR | vir biotechnology inc. | 14.98 | 12,916,700 | 73,754,100 | unchanged | 0.00 | ||
| rapport therapeutics inc. | 22.49 | 3,728,740 | 110,744,000 | unchanged | 0.00 | |||
| maze therapeutics inc. | 21.70 | 4,120,050 | 106,833,000 | unchanged | 0.00 | |||
| q32 bio inc. | 0.13 | 320,482 | 634,554 | unchanged | 0.00 | |||